Development of a New Type of Protease Inhibitors, Efficacious against FIV and HIV Variants
- 1 February 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 121 (6) , 1145-1155
- https://doi.org/10.1021/ja982893p
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cyclic HIV protease inhibitors capable of displacing the active site structural water moleculeDrug Discovery Today, 1997
- Structural Mechanisms of HIV Drug ResistanceAnnual Review of Pharmacology and Toxicology, 1996
- Kinetic Characterization and Cross-Resistance Patterns Of HIV-1 Protease Mutants Selected under Drug PressureBiochemistry, 1995
- The not-so-great escapeNature Structural & Molecular Biology, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Influence of stereochemistry on activity and binding modes for C2 symmetry-based diol inhibitors of HIV-1 proteaseJournal of the American Chemical Society, 1994
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- Pinacol homocoupling of (S)-2-[N-(benzyloxycarbonyl)amino] aldehydes by [V2Cl3(THF)6]2[Zn2Cl6]. Synthesis of C2-symmetric (1S,2R,3R,4S)-1,4-diamino 2,3-diolsThe Journal of Organic Chemistry, 1992
- HIV protease: a novel chemotherapeutic target for AIDSJournal of Medicinal Chemistry, 1991
- Isolation of a T-Lymphotropic Virus from Domestic Cats with an Immunodeficiency-Like SyndromeScience, 1987